Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer

NCT03611179 is registered in ClinicalTrials.gov with Nada Hassan Salah as lead sponsor.

NCT NCT03611179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Lead sponsor
Nada Hassan Salah
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2018
Completion date
September 1, 2022
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced ovarian cancer